WHO picks JN.1 variant for next COVID shots (NYSE:PFE)


Background of SARS-CoV-2 Variant JN.1,Medical health concept

JUN LI/iStock via Getty Images

Following a meeting of an advisory panel this week, the World Health Organization (WHO) recommended drugmakers to update their COVID-19 vaccine formulations to reflect the currently dominant SARS-CoV-2 variant, JN.1.

The decision came on Friday after the agency’s technical experts

Source link

Leave A Reply

Your email address will not be published.